232 related articles for article (PubMed ID: 25833329)
21. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
[TBL] [Abstract][Full Text] [Related]
22. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.
Siva S; Devereux T; Ball DL; MacManus MP; Hardcastle N; Kron T; Bressel M; Foroudi F; Plumridge N; Steinfort D; Shaw M; Callahan J; Hicks RJ; Hofman MS
Technol Cancer Res Treat; 2016 Feb; 15(1):114-21. PubMed ID: 25575575
[TBL] [Abstract][Full Text] [Related]
23. Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.
Siva S; Hardcastle N; Kron T; Bressel M; Callahan J; MacManus MP; Shaw M; Plumridge N; Hicks RJ; Steinfort D; Ball DL; Hofman MS
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):408-17. PubMed ID: 26275510
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Respiratory-gated Positron Emission Tomography/Computed Tomography for Radiotherapy Planning in Patients with Lung Carcinoma - A Systematic Review.
Frood R; Prestwich R; Tsoumpas C; Murray P; Franks K; Scarsbrook A
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):225-232. PubMed ID: 29397271
[TBL] [Abstract][Full Text] [Related]
25. Value of 4-dimensional 18F-FDG PET/CT in the classification of pulmonary lesions.
García Vicente AM; Castrejón AS; León Martín AA; García BG; Pilkington Woll JP; Muñoz AP
J Nucl Med Technol; 2011 Jun; 39(2):91-9. PubMed ID: 21565957
[TBL] [Abstract][Full Text] [Related]
26. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Abelson JA; Murphy JD; Trakul N; Bazan JG; Maxim PG; Graves EE; Quon A; Le QT; Diehn M; Loo BW
Lung Cancer; 2012 Dec; 78(3):219-24. PubMed ID: 23009727
[TBL] [Abstract][Full Text] [Related]
27. Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.
Lamb JM; Robinson CG; Bradley JD; Low DA
Radiother Oncol; 2013 Oct; 109(1):112-6. PubMed ID: 24044792
[TBL] [Abstract][Full Text] [Related]
28. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
29. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
30. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
[TBL] [Abstract][Full Text] [Related]
31. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
32. Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases.
Siva S; Devereux T; Kron T; Gill S; Macmanus M; Bressel M; Chesson B; Callahan J; Pham D; Hicks R; Foroudi F; Ball D
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):244-52. PubMed ID: 24103219
[TBL] [Abstract][Full Text] [Related]
33. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
García Vicente AM; Soriano Castrejón AM; Talavera Rubio MP; León Martín AA; Palomar Muñoz AM; Pilkington Woll JP; Poblete García VM
Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
[TBL] [Abstract][Full Text] [Related]
34. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
[TBL] [Abstract][Full Text] [Related]
35. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
36. [(18)F-FDG PET-CT and respiratory synchronization: effect in the detection and catalogation of pulmonary lesions].
García Vicente AM; Soriano Castrejón A; Talavera Rubio P; Poblete García VM; Palomar Muñoz A; Cepedello Boiso I; González García B; Cordero García JM; Bellón Guardia M; Pilkington Woll JP
Rev Esp Med Nucl; 2009; 28(4):181-7. PubMed ID: 19922830
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
38. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
39. Variation in Lung Tumour Breathing Motion between Planning Four-dimensional Computed Tomography and Stereotactic Ablative Radiotherapy Delivery and its Dosimetric Implications: Any Role for Four-dimensional Set-up Verification?
Ruben JD; Seeley A; Panettieri V; Ackerly T
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):21-7. PubMed ID: 26432188
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
